IVF Services Market By Technology (Conventional IVF, IVF with Egg/Sperm Donation, IVF with Genetic Testing, Egg Freezing, IVF with Surrogacy), By Procedure Type (Fresh IVF Cycle, Frozen IVF Cycle, Natural Cycle IVF, IVF with ICSI), By End-user (Fertility Clinics, Hospitals, IVF Centers, Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The IVF Services Market accounted for USD 22.4 Billion in 2024 and is expected to reach USD 51.7 Billion by 2035, growing at a CAGR of around 7.9% between 2025 and 2035.  The IVF Services Market functions as the industry that delivers assisted reproduction treatments to provide conception assistance to persons and couples.

The service area includes fertility clinics together with hospitals and specialized centers providing patients with embryo transfer services, egg and sperm donation, genetic screening, and surrogacy options. The market develops from three main factors, which include elevating infertility incidence alongside late parenthood patterns and rising acceptance of reproductive technologies based on assistance. Modern advances in AI embryo selection technology, together with improved preservation methods, make the process better and available to more people. Affordable treatment is difficult because, without complete insurance coverage, the costs are too high for patients in developing countries.

Report Scope:

Market Dynamics

Rising Infertility Rates and Delayed Parenthood Trends Among Urban Populations Worldwide

The IVF Services Market shows accelerating growth because infertility rates keep rising globally due to changes to lifestyle and marital patterns and increased stress among the population. The population living in cities of developed economies and emerging markets suffers from increased infertility rates because of their inactive lifestyles, dietary habits, and environmental contamination. Rising understanding concerning assisted reproductive technology methods has created a rapid increase in IVF treatment requests. The IVF success rates gain further improvement from enhanced cryopreservation methods along with AI-assisted embryo selections. 

Urban population delays in beginning parenthood drive expansion in the IVF Services Market because people prefer focusing on achieving financial stability and career goals before family formation. Women who delay childbearing face declining fertility, which drives them to adopt egg-freezing combined with IVF practices. The treatment of assisted reproductive techniques gains wider social acceptance because of supportive government policies together with expanding accessibility of fertility treatments. The market keeps expanding as urban couples expand their demand for fertility solutions.

Technological Advancements Enhancing Success Rates and Reducing IVF Treatment Costs

The IVF Services Market is experiencing quick expansion due to technological developments that boost treatment success rates along with efficiency. The selection methods with AI assistance and time-lapse imaging, as well as Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening, increase successful implantation risks by identifying optimal embryos. Cryopreservation technology developments now improve frozen embryo survivability, which results in better outcomes for frozen IVF therapy cycles. The new advancements in IVF treatments decreased the necessity of multiple treatment cycles, thus increasing the effectiveness and accessibility of the procedure. 

Current IVF Services Market costs decrease primarily through automated procedures together with enhanced laboratory protocols and optimized treatment protocols. Through robotic assistance in surgical procedures along with microfluidic sperm sorting technologies, both clinical success rates rose, and human-related mistakes were eliminated while minimizing operational costs. Fertility clinics compete more strongly, and numerous government assistance programs across regions contribute to the general decline in IVF treatment costs. More accessible fertility care becomes available to couples worldwide because IVF treatments continue improving in affordability.

High Cost of IVF Treatments and Limited Insurance Coverage in Several Countries

A barrier exists in the IVF Services Market since its high price puts care out of reach for couples who want help with infertility. The total financial burden of IVF treatment includes laboratory work costs and medical drugs, along with state-of-the-art screening methods and embryo preservation services. Some nations block their patients from receiving IVF treatment because they fail to provide government support and money for fertility treatments. The high price of treatment leads most couples to delay their infertility treatment or choose fertility tourism, which targets more affordable regions for their procedures. 

The small extent of insurance coverage across various countries functions as an obstacle to market growth since fertility treatments maintain partial or no support from insurance plans. Most patients have to cover IVF expenses because insurance companies label the treatment as elective. Financial barriers prevent several people from seeking treatment, particularly in regions with low and middle income. The IVF Services Market will achieve global market growth expansion through expanded insurance coverage and government-established reimbursement systems.

Growing Medical Tourism in Emerging Markets Offering Affordable and Advanced IVF Treatments

The IVF Services Market demonstrates substantial growth because emerging markets allow patients from all over the world to access advanced fertility treatments at affordable rates. International patients now choose IVF treatment facilities in India along with Thailand, Mexico, and Turkey to receive high-quality medical services. High-cost couples from Europe and North America choose these destinations because they find experienced specialists and state-of-the-art facilities combined with cost-effective treatment. These healthcare locations have become more popular for fertility treatment because they offer both shorter wait times and customized care experiences to patients. 

The IVF Services Market of emerging economies undergoes technological enhancements as well as infrastructure advancements due to rising medical tourism patterns. Fertility tourism receives support from both public authorities and private healthcare facilities through medical visa programs and financial stimulus. The upward trend of global IVF treatment demand in emerging markets drives industry competition and innovation because healthcare costs are becoming more accessible.

Rising Investments in Fertility Clinics and Expanding Service Offerings by Providers

The IVF Services Market receives increasing funding from fertility clinics, which allows them to develop infrastructure to support a rising patient base. The development of leading-edge fertility clinics receives financial backing from both healthcare organizations and individual investors through investments in state-of-the-art facilities, including AI-assisted embryo selection and genetic screening technology. The increased investments are enhancing both access and treatment results, which brings in greater numbers of patients pursuing fertility care. Hospitals that join forces with specialized IVF clinics achieve better service quality and extended access to assisted reproductive technologies for their patients. 

The growth of the IVF Services Market expands due to providers who extend their services to include comprehensive fertility treatments above traditional procedures. Medical clinics have started to provide egg-freezing services combined with surrogacy programs, along with complete fertility wellness plans that include nutritional and lifestyle counseling. Improved cryopreservation methods, together with minimally invasive procedures, enhance patient outcomes and, at the same time, improve their treatment experience. Through ongoing development and well-planned expansion approaches, fertility providers deliver improved customized treatment options to people looking for assisted reproduction assistance.

Industry Experts Opinion

“As more and more couples choose assisted reproductive technologies like IVF, conversations around infertility have become more open. Seeking infertility treatment is no longer a taboo but rather a courageous step towards fulfilling the dream of parenthood.”

• Urjitha Rajagopalan, Director, MGM Healthcare

“Australia has long been at the forefront of IVF innovation, establishing itself as a global leader in reproductive medicine, as the country was among the first in the world to achieve successful IVF births and has a history of groundbreaking research and clinical advancements dating back to the 1980s. Our partnership with Virtus and IVFA broadens access to Fertilo for patients worldwide, beginning with one of Australia's most respected fertility networks.”

• Dr. Dina Radenkovic, Gameto’s CEO and Co-founder

Segment Analysis

Based on Technology, the IVF Services Market is classified as Conventional IVF, IVF with Egg/Sperm Donation, IVF with Genetic Testing (PGD/PGS), Egg Freezing, and IVF with Surrogacy. Standard IVF stands as the preferred choice for many clinics because it delivers good results while reproductive science continues to improve. The use of IVF with Genetic Testing (PGD/PGS) is growing more popular because it diagnoses genetic disorders better and creates higher implantation success along with reducing pregnancy losses. The demand for egg freezing continues to grow because women need to postpone having children and safeguard their fertility. The growth of IVF with Egg/Sperm Donation services continues to rise because infertility rates are increasing and so are requests for parenthood by same-sex couples. Market growth for this segment occurs because of technological advances that include AI-based embryo selection technology combined with enhanced cryopreservation technologies. 

Based on Procedure Type, the IVF Services Market is classified as Fresh IVF Cycle, Frozen IVF Cycle, Natural Cycle IVF, and IVF with ICSI. Fresh IVF Cycle dominates the market because it leads to high fertilization rates, and patients prefer immediate embryo transfer as a procedure. The Frozen IVF Cycle segment demonstrates significant expansion because of improved cryopreservation methods, which produce better results when embryos survive freezing processes.

The treatment of male infertility through IVF with ICSI (Intracytoplasmic Sperm Injection) features broad medical application because this method improves sperm-egg fertilization through direct sperm egg injection. The Natural Cycle IVF has started to receive growing interest because it uses minimal medication, thus attracting women who want a natural method for conception. Primary factors contributing to expansion in specific infertility procedures include growing infertility statistics, enhanced medical research, and deepening public knowledge about reproductive medicine.

Regional Analysis

North America is the largest region in the global IVF Services Market because of sophisticated healthcare systems and high infertility cases together with the rising need for fertility assistance technologies. The United States leads in the region because it contains major fertility clinics, beneficial reimbursement programs, and an expanding understanding of IVF medical procedures. Prelude Fertility and CARE Fertility use AI embryo selection technologies as well as time-lapse imaging in their approaches to boost IVF success. Innovations involving embryo testing without invasiveness and advanced approaches for embryo preservation have resulted in improved patient outcomes. Market expansion in this region receives additional support from both government initiatives and expanding fertility treatment coverage under insurance. 

Asia-Pacific is the fastest-growing region in the IVF Services Market as it deals with expanding infertility cases alongside increasing accessibility of medical treatments throughout the area. The market expansion for fertility clinics throughout India, China, and Japan continues at a fast pace as Indira IVF, together with Virtus Health, conducts investments into AI-based diagnostic tools and robotic-assisted IVF procedures. Modern reproductive healthcare in the region experiences continuing renovation over recent advances like improved genetic screening procedures and fertility treatments grounded on stem cells. Government support for assisted reproductive technologies combined with rising awareness about these technologies has created Asia-Pacific as an essential growth center for the IVF industry.

Competitive Landscape

IVF Services Market competition centers on multiple stakeholders who concentrate on fostering technological progress and broadening service availability as well as building cooperative partnerships. The market leadership position belongs to Virtus Health, together with NMC Healthcare and Indira IVF because of their extensive clinic networks and advanced reproductive technologies. The success rates of Prelude Fertility and CARE Fertility increase through their personalized treatments and AI-based embryo selection strategy.  Genea Pty Limited and Theramex spend their resources on research to improve IVF protocols while creating new fertility solutions.

Fertility First and Ballarat IVF work to provide affordable treatment that reduces IVF costs for patients. AI-based embryo selection technology from CARE Fertility represents one of the latest advances as well as improved methods for freezing embryos and advanced monitoring techniques through time-lapse imaging.  Organizations like NMC Healthcare enhance their worldwide business reach by carrying out strategic mergers along with acquisitions through their purchase of Eugin Group. The increase in fertility tourism throughout Asia-Pacific and Europe has motivated companies to boost their service affordability and success rates to compete more intensely in this market.

IVF Services Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In December 2024, Gameto, a women’s health biotechnology company dedicated to advancing innovative solutions in reproductive health, announced a partnership with the Australian-based IVF clinic chain IVFAustralia (IVFA), part of the Virtus Health group. Under this partnership, Gameto’s product, Fertilo, will be available for patients at select IVFA/Virtus clinics.
• In September 2024, MGM Healthcare announced the launch of its cutting-edge In-Vitro Fertilization (IVF) services. The newly established Varam IVF Centre at MGM Healthcare aims to provide advanced fertility treatments and personalized care, bringing together specialists with state-of-the-art technology and extensive ancillary services all under one roof.

Report Coverage:

By Technology

• Conventional IVF
• IVF with Egg/Sperm Donation
• IVF with Genetic Testing (PGD/PGS)
• Egg Freezing
• IVF with Surrogacy

By Procedure Type

• Fresh IVF Cycle
• Frozen IVF Cycle
• Natural Cycle IVF
• IVF with ICSI

By End-user

• Fertility Clinics
• Hospitals
• IVF Centers
• Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Virtus Health
• Indira IVF Hospital Private Limited
• NMC Healthcare
• Prelude Fertility, Inc.
• Genea Pty Limited.
• CARE Fertility
• Theramex
• Fertility First
• Ballarat IVF
• Adora Fertility
• Pacific Fertility Center
• Advanced Fertility Center of Chicago
• EUGIN clinic
• Fakihivf
• Aspire Fertility
• Genetics & IVF Institute, INC.

Frequently Asked Questions (FAQs)